Literature DB >> 20466015

The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist.

Katja Koivula1, Sergio Rondinelli, Johnny Näsman.   

Abstract

Muscarinic toxins (MTs) are three-finger folded peptides isolated from mamba snake venoms. In this report we describe a selective antagonistic interaction of MTalpha with the human alpha(2B)-adrenoceptor. In a functional assay, measuring the alpha(2B)-adrenoceptor-induced increase in intracellular [Ca(2+)], we found that both venomous MTalpha and synthetic MTalpha inhibited the response in a concentration-dependent way. MTalpha did not affect the responses of alpha(2A)-, alpha(2C)-, alpha(1A)- or alpha(1B)-adrenoceptors. To further explore the binding of MTalpha to the alpha(2B)-adrenoceptor, we performed ligand binding experiments on Sf9 cell homogenates with [(3)H]RX821002 as reporter ligand. MTalpha bound to the receptor rather slowly requiring about 60 min to reach equilibrium. In equilibrium binding experiments, MTalpha displaced the radioligand with an IC(50) of 3.2 nM, but was not able to displace all bound radioligand. Using a saturation binding protocol, we found that MTalpha suppressed the maximum binding without any greater impact on the affinity of the radioligand, indicating a non-competitive mode of inhibition. The toxin bound reversibly to alpha(2B)-adrenoceptor, but extensive washing was needed for full recovery of binding sites at high toxin concentrations. Surprisingly, MTalpha did not affect [(3)H]-N-methylscopolamine binding to the muscarinic receptor subtypes at concentrations found to fully block alpha(2B)-adrenoceptors, showing that the toxin is a more potent antagonist for the alpha(2B)-adrenoceptor than for muscarinic receptors. These findings should open up new views in terms of selective adrenoceptor drug design as well as in elucidation of alpha(2)-adrenoceptor physiology. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466015     DOI: 10.1016/j.toxicon.2010.05.001

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  12 in total

1.  Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease.

Authors:  Justyna Ciolek; Helen Reinfrank; Loïc Quinton; Say Viengchareun; Enrico A Stura; Laura Vera; Sabrina Sigismeau; Bernard Mouillac; Hélène Orcel; Steve Peigneur; Jan Tytgat; Laura Droctové; Fabrice Beau; Jerome Nevoux; Marc Lombès; Gilles Mourier; Edwin De Pauw; Denis Servent; Christiane Mendre; Ralph Witzgall; Nicolas Gilles
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Authors:  K Näreoja; J P Kukkonen; S Rondinelli; D M Toivola; J Meriluoto; J Näsman
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Three-Finger Toxins from Brazilian Coral Snakes: From Molecular Framework to Insights in Biological Function.

Authors:  Jessica Matos Matos Kleiz-Ferreira; Nuria Cirauqui; Edson Araujo Araujo Trajano; Marcius da Silva da Silva Almeida; Russolina Benedeta Benedeta Zingali
Journal:  Toxins (Basel)       Date:  2021-04-30       Impact factor: 4.546

4.  Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein.

Authors:  Sergio Rondinelli; Katja Näreoja; Johnny Näsman
Journal:  Toxins (Basel)       Date:  2011-11-11       Impact factor: 4.546

5.  Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors.

Authors:  Carole Fruchart-Gaillard; Gilles Mourier; Guillaume Blanchet; Laura Vera; Nicolas Gilles; Renée Ménez; Elodie Marcon; Enrico A Stura; Denis Servent
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

6.  Three-fingered RAVERs: Rapid Accumulation of Variations in Exposed Residues of snake venom toxins.

Authors:  Kartik Sunagar; Timothy N W Jackson; Eivind A B Undheim; Syed A Ali; Agostinho Antunes; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2013-11-18       Impact factor: 4.546

7.  RNA-seq and high-definition mass spectrometry reveal the complex and divergent venoms of two rear-fanged colubrid snakes.

Authors:  James J McGivern; Kenneth P Wray; Mark J Margres; Michelle E Couch; Stephen P Mackessy; Darin R Rokyta
Journal:  BMC Genomics       Date:  2014-12-03       Impact factor: 3.969

8.  Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.

Authors:  Arhamatoulaye Maïga; Jon Merlin; Elodie Marcon; Céline Rouget; Maud Larregola; Bernard Gilquin; Carole Fruchart-Gaillard; Evelyne Lajeunesse; Charles Marchetti; Alain Lorphelin; Laurent Bellanger; Roger J Summers; Dana S Hutchinson; Bronwyn A Evans; Denis Servent; Nicolas Gilles
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

9.  BmK-YA, an enkephalin-like peptide in scorpion venom.

Authors:  Yan Zhang; Junyan Xu; Zhiwei Wang; Xiuli Zhang; Xinmiao Liang; Olivier Civelli
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

10.  Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins.

Authors:  Guillaume Blanchet; Doria Alili; Adèle Protte; Gregory Upert; Nicolas Gilles; Livia Tepshi; Enrico A Stura; Gilles Mourier; Denis Servent
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.